http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2868321-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcd16a683fd9e9a1cb90ed492cd8e925
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-46
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
filingDate 2013-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2cdd729ea74e7aa6fb7a301835b2598
publicationDate 2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2868321-A1
titleOfInvention A composition or group of compositions for inhibiting autocrine HCG production in adult human cells
abstract The composition for inhibitting autocrine HCG (Human Chorionic Gonadotropin) production in adult human cells, by administration of a composition containing at least one active component, said active agent being a competitively binding progesterone antagonist strongly binding to steroid receptors of human cells.
priorityDate 2013-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6316432-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6608074-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2210585-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994

Total number of triples: 28.